YTX-7739

N/A

Report date: 2024/12/11 14:40:00
NMEFirst In Class

Base Information

Drug NameYTX-7739
Drug Alias NameYTX-7739
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl-CoA desaturase inhibitors
TargetsAcyl-CoA desaturase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesYumanity Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & JohnsonYumanity Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A